A and B i believe, hope it helped.
<span>An insulin receptor is a neurotransmitter that is activated by the presence of insulin. This receptor is usually represented by the abbreviation (IR),</span>
Type 1 Diabetic here! I can help!! so basically the receptor for insulin is a large protein that binds to insulin and passes its message into the cell. It has several functional parts. Two copies of the protein chains come together on the outside of the cell to form the receptor site that binds to insulin.
I hope this helped :)
Antagonistic is the term for the phenomenon that occurs when two hormones present together to produce effects that are weaker than the effects of either one acting alone.
An antagonism, in ecology is an association between the organisms in which one benefits at the expense of the other. In Biology, it can be defined as A biological response to the exposure to multiple substances which is very less than would be predicted if the known effects of the individual substances were added together. For example, Your little sister or brother benefiting by disturbing you while you study.
Learn more about antagonistic here
brainly.com/question/9455401
#SPJ4
The post-eradication era is a period of history for which there has been no precedent whatsoever in terms of a zero base of immunity. Cessation of immunization will eventually create a population susceptible to widespread infection in the event of accidental or intentional reintroduction or re-emergence of the eradicated virus. Thus, even after immunization ceases, vaccine production must continue.
However, many currently available vaccines may not be appropriate for continued post-eradication vaccine production or reinstatement. Vaccines must be continually improved and ongoing vaccination research maintained. Other potentially useful antiviral strategies—antivirals, prophylaxis, and probiotics—must also be considered as means to strengthen the immune system and serve as adjuvant or prophylactic therapies.
In the case of polio, for example, it remains to be determined which vaccine (oral polio vaccine [OPV] or inactivated polio vaccine [IPV]), or variant thereof, should be produced in the post-eradication, post-vaccination era. A detailed plan for vaccine production will require more information on OPV-derived viral persistence and transmission, as well as continuing dialogue between public health and research communities in order to ensure that appropriate vaccination research continues.
